February 27, 2024 / 01:21 PM IST
Reported Consolidated quarterly numbers for Venus Remedies are:Net Sales at Rs 143.42 crore in December 2023 up 22.69% from Rs. 116.90 crore in December 2022.
Story continues below Advertisement
Quarterly Net Profit at Rs. 6.85 crore in December 2023 up 108.21% from Rs. 3.29 crore in December 2022.
EBITDA stands at Rs. 14.39 crore in December 2023 up 20.82% from Rs. 11.91 crore in December 2022.
Venus Remedies EPS has increased to Rs. 5.13 in December 2023 from Rs. 2.46 in December 2022.
Venus Remedies shares closed at 345.20 on February 26, 2024 (NSE) and has given 44.25% returns over the last 6 months and 109.91% over the last 12 months.
| Venus Remedies | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 143.42 | 167.72 | 116.90 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 143.42 | 167.72 | 116.90 | | EXPENDITURE | | Consumption of Raw Materials | 87.31 | 95.17 | 67.52 | | Purchase of Traded Goods | 2.63 | 4.60 | 2.09 | | Increase/Decrease in Stocks | -0.75 | -2.25 | 0.72 | | Power & Fuel | -- | -- | -- | | Employees Cost | 17.35 | 18.51 | 15.33 | | Depreciation | 6.54 | 6.44 | 7.22 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 24.84 | 33.90 | 23.14 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 5.50 | 11.35 | 0.88 | | Other Income | 2.35 | 3.05 | 3.81 | | P/L Before Int., Excpt. Items & Tax | 7.85 | 14.40 | 4.69 | | Interest | 0.07 | 0.06 | 0.15 | | P/L Before Exceptional Items & Tax | 7.78 | 14.34 | 4.54 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 7.78 | 14.34 | 4.54 | | Tax | 0.93 | 4.40 | 1.25 | | P/L After Tax from Ordinary Activities | 6.85 | 9.94 | 3.29 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 6.85 | 9.94 | 3.29 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 6.85 | 9.94 | 3.29 | | Equity Share Capital | 13.37 | 13.37 | 13.37 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 5.13 | 7.44 | 2.46 | | Diluted EPS | 5.13 | 7.44 | 2.46 | | EPS After Extra Ordinary | | Basic EPS | 5.13 | 7.44 | 2.46 | | Diluted EPS | 5.13 | 7.44 | 2.46 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|